Streetbeat News

Stock Prices

CWS

Eddy Elfenbein, a finance blogger and ETF manager, has outperformed Berkshire Hathaway and ARK Invest with his 'set and hold' strategy through the AdvisorShares Focused Equity ETF (CWS). He creates a yearly 'buy list' of 25 stocks, rarely changing the holdings, and has achieved a 110% return since inception. His 2024 buy list includes companies like Hershey, Intuit, Moody's, HEICO, Silgan Holdings, and Aflac. Elfenbein's 'fulcrum fee' structure aligns his interests with investors, and his fund is nearing $100 million in assets under management.

Portfolio Pulse from Jeannine Mancini

January 23, 2024 | 1:30 pm

SBET

Trading on the stock SBET has been halted at 8:25:00 a.m. ET due to pending news. The halt is in place to ensure a fair and orderly market until the news is released and investors have had time to digest the information.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:25 pm

NOW

Barclays analyst Raimo Lenschow has maintained an Overweight rating on ServiceNow (NYSE:NOW) and increased the price target from $765 to $870, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:23 pm

BMY

PFE

Bristol Myers Squibb (BMY) reported that its Opdivo plus Yervoy combination therapy showed sustained benefits over Pfizer's (PFE) Sutent in treating advanced kidney cancer after 8 years of follow-up in the Phase 3 CheckMate -214 trial. The combination therapy reduced the risk of death by 28% and showed improvements in overall survival, progression-free survival, overall response rate, and duration of response compared to Sutent. These results will be presented at the upcoming American Society of Clinical Oncology 2024 Genitourinary Cancers Symposium. BMY shares saw a premarket increase of 0.52%.

Portfolio Pulse from Vandana Singh

January 23, 2024 | 1:23 pm

VCIG

VCI Global Limited (NASDAQ:VCIG) has secured a consultancy deal with a Singapore-based Fin-MedTech Medical Group for its upcoming IPO on Nasdaq, expected to be completed in 2024/2025. VCI Global will provide services including equity structure, capital market strategy, and regulatory approval assistance. The company will be compensated in shares, with estimated income from the deal between USD 4 million to USD 8 million.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:22 pm

CSLM

Fusemachines, an AI talent solutions provider, has signed a definitive agreement for a business combination with CSLM Acquisition Corp. The merger values the combined entity at $200 million and is anticipated to be finalized by the end of Q2 2024. Upon completion, the company is expected to list on Nasdaq under the ticker symbol 'FUSE'.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:22 pm

RUM

Rumble (NASDAQ:RUM) has publicly launched Rumble Studio, an all-in-one live-streaming tool for creators. The tool allows users to stream to multiple platforms, invite guests, and engage with audiences, with integrations across the Rumble ecosystem and other platforms like YouTube, Twitch, and Facebook. Rumble Studio aims to revolutionize live-streaming monetization with features like live advertiser bidding. The product is available on Web, iOS, and Android, and has received positive feedback from beta users.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:21 pm

IPG

NXST

OMC

Analysts have provided ratings for high-yield dividend stocks in the tech and telecom sector. Nexstar Media Group, Inc. (NXST) has a dividend yield of 3.06% with mixed ratings from Citigroup and Rosenblatt. Omnicom Group Inc. (OMC) offers a 3.15% yield, with Citigroup maintaining a Buy rating despite a price target cut, and Morgan Stanley maintaining an Equal-Weight rating with a reduced price target. The Interpublic Group of Companies, Inc. (IPG) has a 3.86% yield, with Citigroup maintaining a Buy rating and a lowered price target, and Morgan Stanley maintaining an Equal-Weight rating with a reduced price target. Recent news includes Nexstar entering a brokerage agreement, Omnicom posting upbeat Q3 earnings, and Interpublic's CEO departure.

Portfolio Pulse from Avi Kapoor

January 23, 2024 | 1:20 pm

C

COST

NXPI

SMH

On CNBC's 'Halftime Report Final Trades,' analysts recommended NXP Semiconductors (NXPI), Costco (COST), VanEck Semiconductor ETF (SMH), and Citigroup (C). NXP received upgrades from Wolfe Research and Barclays with new price targets. Costco is trialing a new scanning system to prevent unauthorized access. VanEck Semiconductor ETF remains a pick for Anastasia Amoroso. Citigroup is undergoing a leadership overhaul and reported mixed Q4 FY23 results. The stocks showed varied price actions in the last session.

Portfolio Pulse from Avi Kapoor

January 23, 2024 | 1:20 pm

PRPH

ProPhase Labs, Inc. (NASDAQ: PRPH) reports significant progress at its subsidiary Pharmaloz Manufacturing, Inc. (PMI), with price increases and operational enhancements leading to projected profitability in Q1 2024. PMI has signed two new contracts expected to boost lozenge revenues and profitability, and is in discussions with two global brands that could triple revenues by year-end 2024. PMI plans to double capacity with new production lines and automation, aiming for a potential $80-$100 million production capacity. CEO Ted Karkus highlights the growth from a modest unit to a top-tier facility and the potential to reach $100-$200 million in annual revenues by the end of 2025, while also investing in Nebula Genomics and the BE-Smart Esophageal Cancer test.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 1:19 pm